Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

Title
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 98, Issue 10, Pages 1608-1613
Publisher
Springer Nature
Online
2008-05-13
DOI
10.1038/sj.bjc.6604372

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now